| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/31/1997 | DE19602964A1 New morphine derivatives |
| 07/31/1997 | DE19602963A1 New morphine derivatives |
| 07/31/1997 | DE19602962A1 New morphine derivatives |
| 07/31/1997 | DE19602961A1 New morphine derivatives |
| 07/31/1997 | DE19602960A1 New morphine derivatives |
| 07/31/1997 | DE19602959A1 New morphine derivatives |
| 07/31/1997 | DE19602757A1 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung Fixed instant release dosage forms and methods for their preparation |
| 07/31/1997 | DE19602505A1 1-(Pyrazol-4-Indol-3-yl)-Piperidine 1- (pyrazol-4-Indol-3-yl) -piperidines |
| 07/31/1997 | DE19602332A1 Production of lung surfactant preparation in powder form |
| 07/31/1997 | CA2547307A1 Process for preparing ganciclovir derivatives |
| 07/31/1997 | CA2483020A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/31/1997 | CA2248810A1 Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation |
| 07/31/1997 | CA2247953A1 Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists |
| 07/31/1997 | CA2247368A1 Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids |
| 07/31/1997 | CA2245002A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 07/31/1997 | CA2244900A1 Regeneration of nerves in the central nervous system |
| 07/31/1997 | CA2244881A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | CA2244837A1 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 07/31/1997 | CA2244770A1 3-methylimidazopyridines |
| 07/31/1997 | CA2244711A1 Methods of modulating radical formation by mutant cuznsod enzymes |
| 07/31/1997 | CA2244412A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | CA2244378A1 Modified benzimidazole nucleosides as antiviral agents |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2244247A1 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| 07/31/1997 | CA2244189A1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
| 07/31/1997 | CA2244147A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | CA2244136A1 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system |
| 07/31/1997 | CA2244132A1 Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid |
| 07/31/1997 | CA2244117A1 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
| 07/31/1997 | CA2244112A1 Methods of inhibiting colon tumors |
| 07/31/1997 | CA2244063A1 Methods of increasing sphincter competence |
| 07/31/1997 | CA2243964A1 Solid instant-release forms of administration and processes for their production |
| 07/31/1997 | CA2243958A1 Medicaments containing aromatic azo compounds |
| 07/31/1997 | CA2243557A1 Methods and compositions for passive immunotherapy |
| 07/31/1997 | CA2243543A1 Apoptosis inducers |
| 07/31/1997 | CA2243497A1 Substrates and inhibitors for cysteine protease ich-1 |
| 07/31/1997 | CA2243121A1 Aspartyl protease inhibitors |
| 07/31/1997 | CA2242960A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | CA2242761A1 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
| 07/31/1997 | CA2242719A1 Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine |
| 07/31/1997 | CA2242657A1 Method for inducing death of neoplastic cells using piperazine oxirane derivatives |
| 07/31/1997 | CA2242595A1 Optical resolution of methylphenidate by 0,0'-bisaroyl tartaric acids |
| 07/31/1997 | CA2242417A1 Novel administration of thrombopoietin |
| 07/31/1997 | CA2242200A1 Toxoplasma gondii antigen tg20 |
| 07/31/1997 | CA2241992A1 Terpyridine-platinum(ii) complexes |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | CA2196401A1 Method for treatment of biological material |
| 07/31/1997 | CA2196388A1 Substituted diaryldicarboxylic acid diguanidides, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 07/31/1997 | CA2196136A1 2-aryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4] diazepines |
| 07/30/1997 | EP0786522A2 Enzymatic RNA molecules for treatment of stenotic conditions |
| 07/30/1997 | EP0786473A2 Basic protein composition, basic peptide composition and application thereof |
| 07/30/1997 | EP0786472A1 Vaccines and diagnostic assays for Haemophilus influenzae |
| 07/30/1997 | EP0786469A2 Nucleic acid ligands |
| 07/30/1997 | EP0786467A1 Multiple-fucosylated dicarboxylic acids having anti-adhesive properties |
| 07/30/1997 | EP0786458A2 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents |
| 07/30/1997 | EP0786457A1 Azole derivative |
| 07/30/1997 | EP0786455A1 Imidazole derivative |
| 07/30/1997 | EP0786450A2 Process for the preparation of O-demethyltramadol enantiomers |
| 07/30/1997 | EP0786264A2 Devices for treating pulmonary vasoconstriction and asthma |
| 07/30/1997 | EP0786256A2 Obesity protein formulations |
| 07/30/1997 | EP0786255A1 Methods of improving allograft or xenograft tolerance by administration of an LFA-3 or CD2 binding protein |
| 07/30/1997 | EP0786254A1 Preventive or remedy for kidney diseases |
| 07/30/1997 | EP0786253A1 Agent for suppressing tumour growth |
| 07/30/1997 | EP0786251A2 Topical preparation containing a suspension of solid lipid particles |
| 07/30/1997 | EP0785989A1 Microbial synthesis of hiv protease inhibitors |
| 07/30/1997 | EP0785938A1 Fused pyrrolocarbazoles |
| 07/30/1997 | EP0785937A1 2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials |
| 07/30/1997 | EP0785935A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists |
| 07/30/1997 | EP0785934A1 Substituted spiroalkylamino and spiroalkoxy-heterocycles, process for preparing the same and their use as pesticides and fungicides |
| 07/30/1997 | EP0785933A1 Indole derivatives as 5ht1-like agonists |
| 07/30/1997 | EP0785932A1 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
| 07/30/1997 | EP0785930A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b 4? (ltb 4?) antagonists |
| 07/30/1997 | EP0785927A1 Novel benzoxazoles |
| 07/30/1997 | EP0785926A1 New carboxylic acid derivatives, their preparation and their use |
| 07/30/1997 | EP0785924A1 Bis-2-aminopyridines, preparation method therefor and use thereof for controlling parasitic infections |
| 07/30/1997 | EP0785803A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 07/30/1997 | EP0785801A1 Treatment of tissues to reduce subsequent response to injury |
| 07/30/1997 | EP0785794A1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 07/30/1997 | EP0785790A1 Use of anthocyanidin and derivatives for treatment of retroviral infections |
| 07/30/1997 | EP0785789A1 Diazepino-indoles as phosphodiesterase iv inhibitors |
| 07/30/1997 | EP0785788A1 Use of cck-b receptor antagonists for the treatment of sleep disorders |
| 07/30/1997 | EP0785787A1 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus |
| 07/30/1997 | EP0785786A1 Microbial synthesis of hiv protease inhibitors |
| 07/30/1997 | EP0785785A1 Methods of inhibiting conditions associated with neuropeptide y |
| 07/30/1997 | EP0785784A1 4-heterocyclic piperidines promote release of growth hormone |
| 07/30/1997 | EP0785783A1 Sabeluzole oral suspensions |
| 07/30/1997 | EP0785782A1 Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid-like activity |
| 07/30/1997 | EP0785781A2 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 07/30/1997 | EP0785780A1 Ophthalmic and aural compositions containing diclofenac potassium |
| 07/30/1997 | EP0785779A1 Low dosage ketoprofen |
| 07/30/1997 | EP0785778A1 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| 07/30/1997 | EP0785775A1 Melt-extruded orally administrable opioid formulations |
| 07/30/1997 | EP0785772A1 Lyophilizate of lipid complex of water insoluble camptothecins |
| 07/30/1997 | EP0785771A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant |
| 07/30/1997 | EP0785770A1 Hemorrhoidal compositions and method of use |
| 07/30/1997 | EP0785769A1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
| 07/30/1997 | EP0785766A1 Particles including degradable material and anti-microbial agent |
| 07/30/1997 | EP0785715A1 Method for delipidation of skin and cerumen removal |
| 07/30/1997 | EP0785714A1 Antimicrobial composition |
| 07/30/1997 | EP0735859B1 A pharmaceutical composition for the intranasal administration of hydroxocobalamin |